Work

Predictive Markers of High-Grade or Serious Treatment-Emergent Infections with Daratumumab-Based Regimens in Newly Diagnosed Multiple Myeloma (NDMM)

Year: 2020

Type: article

Source: Blood

DOI: 10.1182/blood-2020-134923

Authors: Niels W. C. J. van de Donk, Sonja Zweegman, Jesus F. San-Miguel, Meletios A Dimopoulos, Michele Cavo, Kenshi Suzuki, Cyrille Touzeau, Saad Z. Usmani, Aurore Perrot, Huiling Pei, Anupa Kudva, Rian Van Rampelbergh, Jon Ukropec, Kevin Leary, Robin Carson, Ming Qi, Ajai Chari

Institutions: Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam, Navarre Institute of Health Research, Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada, National and Kapodistrian University of Athens, University of Bologna, Japanese Red Cross Medical Center, Nantes Université, Levine Cancer Institute, Université Toulouse III - Paul Sabatier, Centre Hospitalier Universitaire de Toulouse, Institut universitaire du cancer de Toulouse Oncopole, Université de Toulouse, Janssen Research & Development (United States), Janssen (Belgium), Icahn School of Medicine at Mount Sinai

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3097458690

FWCI: 0.941

Cites:

Cited by: 9

Related to: 10